AYURF
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
Capitalization
4.23M
HNSPF
Price
$4.58
Change
-$0.62 (-11.92%)
Updated
Aug 25 closing price
Capitalization
28.29B
Interact to see
Advertisement

AYURF vs HNSPF

Header iconAYURF vs HNSPF Comparison
Open Charts AYURF vs HNSPFBanner chart's image
AYURCANN
Price$0.02
Change-$0.00 (-0.00%)
Volume$10.11K
Capitalization4.23M
Hansoh Pharmaceutical Group
Price$4.58
Change-$0.62 (-11.92%)
Volume$800
Capitalization28.29B
AYURF vs HNSPF Comparison Chart in %
Loading...
AYURF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AYURF vs. HNSPF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYURF is a Buy and HNSPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AYURF: $0.02 vs. HNSPF: $4.58)
Brand notoriety: AYURF and HNSPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYURF: 40% vs. HNSPF: 85%
Market capitalization -- AYURF: $4.23M vs. HNSPF: $28.29B
AYURF [@Pharmaceuticals: Generic] is valued at $4.23M. HNSPF’s [@Pharmaceuticals: Generic] market capitalization is $28.29B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYURF’s FA Score shows that 0 FA rating(s) are green whileHNSPF’s FA Score has 2 green FA rating(s).

  • AYURF’s FA Score: 0 green, 5 red.
  • HNSPF’s FA Score: 2 green, 3 red.
According to our system of comparison, HNSPF is a better buy in the long-term than AYURF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYURF’s TA Score shows that 4 TA indicator(s) are bullish while HNSPF’s TA Score has 3 bullish TA indicator(s).

  • AYURF’s TA Score: 4 bullish, 3 bearish.
  • HNSPF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, HNSPF is a better buy in the short-term than AYURF.

Price Growth

AYURF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while HNSPF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($28.3B) has a higher market cap than AYURF($4.23M). HNSPF YTD gains are higher at: 114.701 vs. AYURF (50.000).
AYURFHNSPFAYURF / HNSPF
Capitalization4.23M28.3B0%
EBITDA-1.61MN/A-
Gain YTD50.000114.70144%
P/E RatioN/A40.89-
Revenue29.8MN/A-
Total Cash1.08MN/A-
Total Debt2.74MN/A-
TECHNICAL ANALYSIS
Technical Analysis
AYURFHNSPF
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
25%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
40%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
13%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
28%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
26%
Advances
ODDS (%)
N/A
Bullish Trend 19 days ago
90%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
AYURF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
AXS.X2.3944440.088735
+3.85%
Axie Infinity cryptocurrency
BICO.X0.0949500.001500
+1.61%
Biconomy cryptocurrency
ACE.X0.4966710.005562
+1.13%
Fusionist cryptocurrency
LTO.X0.0082300.000076
+0.94%
LTO Network cryptocurrency
OMF61.50-1.11
-1.77%
OneMain Holdings

AYURF and

Correlation & Price change

A.I.dvisor tells us that AYURF and PRFX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYURF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYURF
1D Price
Change %
AYURF100%
N/A
PRFX - AYURF
21%
Poorly correlated
-12.62%
HNSPF - AYURF
11%
Poorly correlated
N/A
STEK - AYURF
5%
Poorly correlated
-3.45%
BFRI - AYURF
3%
Poorly correlated
+0.64%
HLBBF - AYURF
-0%
Poorly correlated
N/A
More

HNSPF and

Correlation & Price change

A.I.dvisor tells us that HNSPF and RMTI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNSPF and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
RMTI - HNSPF
24%
Poorly correlated
-3.57%
AYURF - HNSPF
11%
Poorly correlated
N/A
AKAN - HNSPF
8%
Poorly correlated
-2.54%
IXHL - HNSPF
5%
Poorly correlated
-9.48%
BFRI - HNSPF
4%
Poorly correlated
+0.64%
More